↓ Skip to main content

Targeting activated PI3K/mTOR signaling overcomes acquired resistance to CDK4/6-based therapies in preclinical models of hormone receptor-positive breast cancer

Overview of attention for article published in Breast Cancer Research, August 2020
Altmetric Badge

Citations

dimensions_citation
86 Dimensions

Readers on

mendeley
75 Mendeley
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output. Click here to find out more.
Title
Targeting activated PI3K/mTOR signaling overcomes acquired resistance to CDK4/6-based therapies in preclinical models of hormone receptor-positive breast cancer
Published in
Breast Cancer Research, August 2020
DOI 10.1186/s13058-020-01320-8
Pubmed ID
Authors

Neil A. O’Brien, Martina S. J. McDermott, Dylan Conklin, Tong Luo, Raul Ayala, Suruchi Salgar, Kevin Chau, Emmanuelle DiTomaso, Naveen Babbar, Faye Su, Alex Gaither, Sara A. Hurvitz, Ronald Linnartz, Kristine Rose, Samit Hirawat, Dennis J. Slamon

Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 75 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Unknown 75 100%

Demographic breakdown

Readers by professional status Count As %
Researcher 14 19%
Student > Ph. D. Student 10 13%
Student > Master 7 9%
Other 6 8%
Student > Postgraduate 5 7%
Other 11 15%
Unknown 22 29%
Readers by discipline Count As %
Biochemistry, Genetics and Molecular Biology 21 28%
Medicine and Dentistry 10 13%
Agricultural and Biological Sciences 6 8%
Pharmacology, Toxicology and Pharmaceutical Science 5 7%
Unspecified 1 1%
Other 3 4%
Unknown 29 39%